Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2018 Jun 18;16(1):37.
doi: 10.1186/s12969-018-0254-9.

Reliability of LoSCAT score for activity and tissue damage assessment in a large cohort of patients with Juvenile Localized Scleroderma

Affiliations
Observational Study

Reliability of LoSCAT score for activity and tissue damage assessment in a large cohort of patients with Juvenile Localized Scleroderma

Anna Agazzi et al. Pediatr Rheumatol Online J. .

Abstract

Objectives: To assess reliability of the two indexes of Localized Scleroderma Cutaneous Assessment Tool (LoSCAT), the modified Localized Scleroderma Skin Severity Index (mLoSSI) and the Localized Scleroderma Skin Damage Index (LoSDI), when applied by clinicians with different experience in scoring and managing patients with JLS. Secondary aim was to compare LoSCAT and infrared thermography (IRT) in monitoring lesions over time.

Methods: Consecutive children with Juvenile Localized Scleroderma (JLS) were blindly evaluated by three examiners with different experience in Paediatric Rheumatology and with no experience in LoSCAT use. At each visit, patients were assessed by LoSCAT and IRT. Sensitivity to change of LoSCAT and IRT was assessed in a group of patients 3-6 months later. Inter-rater reliability was assessed by Intraclass Correlation Coefficient (ICC) and variance analysis (ANOVA).

Findings: Forty-seven patients (129 lesions) entered the study, and 26 (79 lesions) were re-evaluated with same modality after 4.5 (SD 1.5) months. mLoSSI showed excellent inter-rater reliability expressed by ICC 0.965 confirmed by ANOVA. Similarly, inter-rater reliability for LoSDI was good (ICC = 0.774) but worse concordance among examiners was observed. A comparable improvement of mLoSSI in all anatomic sites was noted by all examiners in 79 lesions examined in two subsequent visits and was consistent with thermography.

Conclusions: Different clinical experience in JLS did not influence clinical judgement in mLoSSI which showed excellent concordance, whereas LoSDI is less precise in damage assessment and not completely reliable in monitoring skin changes. Infrared thermography confirms to be a helpful tool for detecting disease activity and reliable in monitoring lesions over time.

Keywords: Children; LoSCAT; Localized scleroderma; Morphea; Outcome measures; Thermography.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

No ethics approval was needed since LoSCAT and thermography are currently in use in the routine assessment of children with Localized Scleroderma. All participants gave their informed consent to participate.

Consent for publication

Obtained.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Frequency of different scores for each domain of mLoSSI (a) and LoSDI (b) at baseline visit. Bars represent the frequencies of each domain score. Distribution recorded by three examiners from 129 lesions. N/E = new lesion/lesion extension, ER = erythema, ST = skin thickness, DAT = dermal atrophy, SAT = subcutaneous atrophy, DP = dyspigmentation
Fig. 2
Fig. 2
Relative variation between first and second visit for mLoSSI score and IRT. Bars represent the relative variation for the three examiners and thermography in 11 different anatomic areas
Fig. 3
Fig. 3
Relative variation between first and second visit for LoSDI score. Bars represent the relative variation for the three examiners in 11 different anatomic areas

Similar articles

Cited by

References

    1. Zulian F. Systemic sclerosis and localized scleroderma in childhood. Rheum Dis Clin N Am. 2008;34(1):239–255. doi: 10.1016/j.rdc.2007.11.004. - DOI - PubMed
    1. Laxer RM, Zulian F. Localized scleroderma. Curr Opin Rheumatol. 2006;18(6):606–613. doi: 10.1097/01.bor.0000245727.40630.c3. - DOI - PubMed
    1. Zulian F, Athreya BH, Laxer R, Nelson AM, Feitosa de Oliveira SK, Punaro MG, et al. Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study. Rheumatol (Oxford) 2006;45(5):614–620. doi: 10.1093/rheumatology/kei251. - DOI - PubMed
    1. Zulian F, Meneghesso D, Grisan E, Vittadello F, Belloni Fortina A, Pigozzi B, et al. A new computerized method for the assessment of skin lesions in localized scleroderma. Rheumatol (Oxford) 2007;46(5):856–860. doi: 10.1093/rheumatology/kel446. - DOI - PubMed
    1. Martini G, Murray KJ, Howell KJ, Harper J, Atherton D, Woo P, et al. Juvenile-onset localized scleroderma activity detection by infrared thermography. Rheumatol (Oxford) 2002;41(10):1178–1182. doi: 10.1093/rheumatology/41.10.1178. - DOI - PubMed

Publication types